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Abstract 
Biotin protein ligase (BPL, EC: 6.3.4.15) catalyses the formation of biotinyl-5’-AMP from biotin and ATP, 
and the succeeding biotinylation of the biotin carboxyl carrier protein (BCCP). We describe the crystal 
structures at 2.4 Å resolution of the class I BPL from the hyperthermophilic bacteria Aquifex aeolicus 
(AaBPL) in its ligand-free form and in complex with biotin and ATP. The solvent-exposed β- and γ- 
phosphates of ATP are located in the inter-subunit cavity formed by the N- and C-terminal domains. The 
Arg40 residue from the conserved GXGRXG motif is shown to interact with the carboxyl group of biotin and 
to stabilise the α- and β- phosphates of the nucleotide. The structures of the mutant AaBPL R40G in both the 
ligand-free and biotin-bound forms reveal that the mutated loop has collapsed, thus hindering ATP binding. 
Isothermal titration calorimetry experiments indicate that the presence of biotin is not required for ATP 
binding to wildtype AaBPL in the absence of Mg
2+
 ions and the binding of biotin and ATP has been 
determined to occur via a random but cooperative process. The affinity for biotin is relatively unaffected by 
the R40G mutation. In contrast, the thermodynamic data indicate that binding of ATP to AaBPL R40G is very 
weak in the absence or presence of biotin. The AaBPL R40G mutant remains catalytically active but shows 
poor substrate specificity - mass spectrometry and western blot studies reveal that the mutant biotinylates the 
target A. aeolicus BCCPΔ67 fragment but also BSA, and is subject to self-biotinylation. 
 
Introduction 
The vitamin biotin plays key metabolic roles when covalently bound to essential carboxylases and 
decarboxylases involved in lipogenesis, glucogenesis, and amino acid degradation.
1
 The enzymatic attachment 
of the biotin co-factor is catalysed by biotin protein ligase (BPL, EC: 6.3.4.15), also known as 
holocarboxylase synthetase (HCS). BPL is exceptionally specific, recognising less than five biotin-dependant 
enzymes in most eukaryotes and in bacteria only the multi-subunit protein acetyl-CoA carboxylase (ACC) is 
biotinylated.
2
 In the functional ACC complex, the biotin prosthetic group is linked via an amide linkage to a 
conserved lysine residue of the biotin carboxyl carrier protein (BCCP) domain.
3
 Biotin mediates (through its 
N1 carboxylated form) the transfer of CO2 from hydrogen carbonate to acetyl-CoA to afford malonyl-CoA.
4
 
The biotinylation reaction catalysed by BPL is Mg
2+
 and ATP dependant and occurs in two steps (Scheme 1). 
The first step generates the reactive intermediate biotinyl-5’-AMP and in the second step, the Nε of the target 
lysine of BCCP reacts with the activated carboxyl group to form biotinylated-BCCP with release of AMP.
5
 
 
Page 2 of 31 
Mechanistically, BPL belongs to the family of adenylating enzymes which includes lipoate protein ligase 
(LplA) and aminoacyl-tRNA synthetase (aaRS). Analysis of the crystal structures of E. coli BPL, BirA, and 
LplA shows that the two enzymes are close structural homologs.
6-8 
Structural similarities have also been 
previously reported between BirA and class II aminoacyl-tRNA synthetases and these suggest that despite 
poor sequence identity, the three enzymes could have arisen from a common ancestor.
7,8
 The BPL enzymes 
have been further classified into four sub-classes, according to their domain structures and their ability to 
control biotin metabolism.
9
 E. coli BirA is a bifunctional class II BPL which has regulatory properties as well 
as biotin-transfer activity. BirA normally acts as a ligase after converting biotin into biotinyl-5’-AMP, but in 
the absence of substrate apo-BCCP, the BirA:biotinyl-5’-AMP complex dimerizes and represses biotin 
biosynthesis by binding of the N-terminal domains to the bidirectional O/P region of the biotin operon (which 
encodes bioABCFD).
10,11 
The biotin sensing/birA regulatory circuit has been used as a paradigm for studies of 
the control of metabolism by a repressor protein controlled by a small molecule co-regulator.
12
 
The structure of BirA has been reported in its ligand-free form, in complex with biotin and with the biotinyl-
5’-AMP analogue, biotinol-5’-AMP.13-16 These structures show three distinct domains: a N-terminal DNA-
binding domain, a large central catalytic domain, and a small C-terminal domain for which the exact function 
remains unclear. The structure of monomeric, ligand-free BirA reveals four disordered surface loops in the 
catalytic domain and shows that disorder-to-order transitions occurring upon biotin binding induce 
dimerization. In the structure of BirA in complex with biotin, the biotin binding loop protects the biotin 
moiety from the solvent while two more loops located at the dimer interface are also ordered. In the structure 
of the BirA:biotinol-5’-AMP complex, the last peptide segment forms the adenylate-binding loop and 
completes the dimer packing. In BirA, the binding of the substrates and the formation of biotinyl-5’- AMP 
occur via an ordered sequential process with ATP binding after biotin and subsequent dimerisation.
17
 
The crystal structures of Pyroccocus horikoshii OT3 BPL (PhBPL) have been determined in the ligand-free 
state and in complex with biotin, ADP, and biotinyl-5’- AMP.18 The class I PhBPL lacks the N-terminal 
DNA-binding domain and acts solely as a ligase but the overall fold of PhBPL has high structural similarity 
with the catalytic and C-terminal subunits of BirA. The structure of ligand-free PhBPL indicates that only the 
biotin binding loop is disordered and that after substrate binding, the intermediate biotinyl-5’-AMP is 
stabilised within the active site via hydrogen-bonds with the loop. The formation of a BPL:BCCP complex 
appears to be required prior to the transfer of the biotin moiety onto the target lysine to ensure the specificity 
of the enzymatic biotinylation reaction. Most recently, the structures of the single and double mutants, PhBPL 
R48A and PhBPL R48A K111A, as well as their complexes with the corresponding C-terminal BCCP domain 
(PhBCCPΔN76) revealed the residues responsible for complex formation and biotin transfer in this 
hypothermophilic species.
19
 A model of the E. coli complex has also been assembled using the structures of 
BirA and the E. coli BCCP87 biotinyl domain, and the complex formed between Aquifex aeolicus BPL and 
the C-terminal fragment BCCPΔ67 has been characterised by chemical cross-linking.20,21 
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The conserved glycine-rich motif, GXGRXG, present in all BPLs (e.g. 45GHGRLN50 in P. horikoshii), is 
located on the turn of the biotin binding loop in the structures of E. coli BirA and PhBPL. In BirA this 
sequence motif, originally thought to be involved in binding the nucleotide portion of ATP, was shown to be 
involved in binding of biotin and the adenylate intermediate.
22
 In contrast, the corresponding loop has been 
shown in PhBPL to interact with biotin, ADP and biotinyl-5’-AMP.18 The two mutants PhBPL R48A and 
PhBPL R48A K11A have been shown to catalyse the formation of holo-BCCPΔN76.19 However, while the 
structure of the single PhBPL mutant in complex with biotinyl-5’AMP has been determined showing near-
identical interactions with the native enzyme, in the structure of PhBPL R48A K11A, only biotin and the 
adenosine moiety are visible. In the BirA structures, the glycine-rich motif plays a role in binding both biotin 
and biotinol-5’-AMP.14,16 Kinetic and thermodynamic studies carried out on single-site mutants of the 
115GRGRRG120 motif of BirA indicate that mutations within this motif alter ligand affinities and affect the 
dimerisation process.
22-24
 Mutant BirA R118G has been shown to have lost its substrate specificity; in vivo and 
in vitro assays have shown that the mutant biotinylates itself as well as non-cognate acceptors.
25
 While the 
mechanism involved in this promiscuous biotinylation is not understood, it has been suggested that it could 
arises as a result of dissociation of the BirA R118G:biotinyl-5’-AMP complex to give free biotin adenylate 
which reacts with available amino groups. Despite the crystallographic data obtained for the BirA and PhBPL 
complexes, the role of the conserved arginine in the normal catalytic process remains unclear. The 
mechanistic importance of this residue is underscored by the observation that mutation of the corresponding 
arginine in the glycine motif of human holocarboxylase synthetase (R508W), which is known to alter its 
affinity for biotin, gives rise to multiple carboxylase deficiency syndrome.
26,27
 
We have investigated the importance of the arginine 40 from the glycine-rich motif in the specificity of the 
biotinylation reaction catalysed by the Aquifex aeolicus BPL (AaBPL). The X-ray structures of the class I 
AaBPL in the ligand-free state and in complex with biotin and ATP are described and these allow us to 
propose a role for the Arg40 residue in substrate binding. Isothermal titration calorimetry experiments have 
been carried out with AaBPL in order to investigate the substrate binding processes. Characterisation of the 
crystal structure of the mutant AaBPL R40G in complex with biotin and complementary ITC experiments 
indicate that the conformation of the active site and ATP binding are strongly affected by the R40G mutation. 
Furthermore, streptavidin western blot studies and mass spectrometric analyses carried out with wildtype 
AaBPL and mutant R40G have shown the importance of the conserved Arg40 in the catalytic process. 
 
Results and Discussion 
1. The Structure of A. aeolicus BPL 
In the structure of the class I AaBPL, the first 186 residues of the 26 kDa (233 aa) protein folds into a large N-
terminal catalytic domain which contains seven β-strands and five α-helices (Figure 1a).21 The smaller C-
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terminal domain (47 aa) is formed by a mixed β-sheet of five strands. This two-domain topology is also 
observed in the structures of E. coli BirA and P. horikoshii BPL.
15,18 
AaBPL displays linear sequence 
similarities with BirA and PhBPL of 20.9 % and 30.6 % sequence identity respectively. Analysis of the 
crystal structures of the three different BPLs reveals that similarities are also observed in their overall folds 
and secondary structures. Several conformational differences, mainly located on the loops involved in 
substrate binding, are observed between the active sites of the three BPLs. In the ligand-free structure of 
AaBPL, residues 37 to 47 of the biotin binding loop (loop β2-β3) containing the 37GRGRLG42 motif are 
disordered, and the active site formed by the strands β3, β6 and β7 is solvent-exposed. The equivalent 
adenylatebinding loop of BirA, which only becomes organised upon ATP binding, is ordered in the ligand-
free structure of AaBPL and the ATP binding site is consequently more preformed.
14,16 
Additionally, in the 
structure of AaBPL, the surface loop connecting the β6 and β7 strands is shifted towards the binding site 
(Figure 1b). 
(a)  
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(b)  
Figure 1.  A cartoon ribbon representation of the apo form of AaBPL and PhBPL (PDB code 2DTO). (a) 
Monomer structure of apo form of AaBPL showing secondary structure elements. The α-helices are coloured 
red and the β-strands are coloured yellow. Secondary structure elements are numbered according to their 
position in the protein sequence. The missing loop is represented by a broken green line. (b) Dimer 
comparison of PhBPL and AaBPL. Left-hand, respectively. Right-hand,6 and β7 strands is marked with an 
asterisk (
⁎
) and the colouring is as for individual images. 
 
The class I PhBPL is dimeric in solution and this dimer is also observed in the crystal form.
18
 The β1-strands 
of each PhBPL monomer are hydrogen-bonded and form the dimer interface (Figure 1b). The crystals of 
AaBPL belong to either the monoclinic space-group P21 or to the orthorhombic space-group P212121 and, like 
the P. horikoshii enzyme, consist of two monomers per asymmetric unit related by a pseudo-two fold axis. 
However, in the structure of apo-AaBPL the β1-strands are located in close proximity but do not form an inter-
subunit β-sheet (Figure 1b). The monomeric nature of AaBPL observed in the crystal structures of the ligand-
free and ligand-bound forms is also found in solution - supported by gel filtration experiments carried out in 
the absence and presence of substrates (data not shown). 
 
2. The biotin and ATP binding sites in AaBPL 
The structure of AaBPL complexed with biotin and ATP (AaBPL:biotin:ATP) was determined at a resolution 
of 2.3 Å (Figure 2a). In the complex, residues 37-47, which form the biotin binding loop and act as a lid to the 
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active site, and the two ligands are fully ordered in the electron density (Figure 2b) The loop stabilises the 
biotin and ATP moieties with strong hydrophobic and hydrophilic interactions. The tetrahydrothiophene ring 
of the biotin is accommodated in the interior of the binding pocket formed by residues Gly119 and Gly121 of 
the β7-strand (Figure 2c) The nitrogen atoms of the biotin ureido group hydrogen-bond with the side chain of 
Gln34 and the backbone carbonyl of Arg38 from the biotin binding loop, as well as the Thr14 from the α1-
helix. In addition, the ureido carbonyl forms hydrogen-bonds with the hydroxyl group of Ser13 from the β1- α1 
loop and the backbone NH of Arg38. The aliphatic tail of the biotin is held by a sandwich of two hydrophobic 
walls formed by the residues Gly106, Val107, and Leu108 from the β6-strand on one side, and on the other 
side, the residues Gly37, Gly39, Trp45, and Leu46 from the biotin binding loop. 
 
(a)  
(b)  
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(c)  
Figure 2.  Stereo views of AaBPL with bound biotin and ATP (AaBPL:biotin:ATP). (a) A cartoon view 
of AaBPL monomer, ATP, biotin and Arg40 are represented as sticks. (b) A close-up view of the active site 
with electron density around ATP, biotin and Arg40. The final omit |Fo| – |Fc| is contoured at 2.5σ. (Green 
chicken wire around ATP and BIOTIN, blue around Arg40) (c) Binding interactions of ATP and biotin within 
the AaBPL protomer A active site. ATP and biotin are coloured with green carbons, H-bonds are shown as 
broken red lines. Residues (Lys192 and Ser233) from the other protomer are annotated with asterisks (*). 
 
The biotin carboxylate is adjacent to the turn of the biotin binding loop and is strongly stabilised by hydrogen-
bonds with the side chain of the Arg40 from the GRGRLG motif and have weak interactions with the Arg40 
backbone NH and the side chain of Lys103 from the β6-strand. The carboxylate group lies toward the outside 
of the active site, near the ATP binding pocket. We find that the oxygen atoms of the biotin carboxylate group 
and the -phosphate of ATP are located in close proximity (approximately 3.5 Å) (Figures 2b and c). 
Therefore, the nucleophilic attack of the carboxylate anion at the α- phosphate of ATP, resulting in the 
formation of the phosphoanhydride bond of biotinyl- 5’-AMP, induces only minor conformational changes to 
the active site. Comparison of the structures of the AaBPL:biotin:ATP and PhBPL:biotinyl-5’-AMP 
complexes shows that the orientations of the adenine ring and sugar moiety of ATP and the biotin within the 
active sites are similar in the two complexes.
18
 
We find that polar and electrostatic interactions with residues from both the adenylatebinding loop (Asn123 
and Ile133) and the biotin binding loop (Trp45 and Leu46) contribute to the correct positioning of the adenine 
ring of ATP in the active site (Figure 2c). The α-phosphate of ATP is stabilised by a network of hydrogen-
bonding interactions with the side chains of Arg40, Arg43 and Lys103. In addition to these interactions, the 
crystal packing allows the formation of hydrogen-bonds between the oxygen atoms of the α-phosphate of ATP 
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and the side chain amino group of Lys192 from the second monomer (monomer B) of the asymmetric unit 
(Figure 2c). The structure of the AaBPL:biotin:ATP complex reveals that the β- and  γ- phosphates of ATP 
protrude from the adenylate binding site pointing into the inter-subunit cavity formed by the N- and C-
terminal domains and are solvent-exposed (Figure 2a). In the crystal, the β-phosphate is stabilised by the 
hydrophilic environment formed by Asp96 from the β5-strand and the side chains of Arg40, Lys92 and 
Lys103. The γ-phosphate interacts weakly with the hydroxyl group of Tyr98 and the side chain of Lys92 from 
the β4- and β5- strands respectively. Interestingly, the structure of the biotin-ATP complex indicates that the 
backbone carbonyl of Leu230 and the hydroxyl group of Ser229 from the β12-strand of the C-terminal domain 
also form hydrogen-bonds with the oxygen atoms of the γ-phosphate (Figure 2c). The terminal diphosphate, is 
thus in a position which allows binding of Mg
2+
 resulting in the easy elimination of the pyrophosphate leaving 
group and the formation of biotinyl-5’-AMP. It is perhaps noteworthy that in this structure the side chain of 
Arg231 points towards the phosphate binding cavity. In BirA the equivalent residue (Arg317) has been shown 
by mutagenesis to be directly involved in MgATP binding.
28
 
 
3. Capture of the biotin-ATP intermediate complex of AaBPL 
In the AaBPL and PhBPL complexes with biotin and ATP, the biotin binding loops display significant 
conformational differences which can be attributed to the sequence differences within their respective glycine 
rich motifs - AaBPL 37GRGRLG42 and PhBPL 45GHGRLN50 (Figure 3). In comparison to the 
AaBPL:biotin:ATP structure, in the PhBPL complex, the loop is displaced and the side chain of the Asn50 is 
solventexposed and interacts weakly with the His46 (Bagautdinov and Kunishima, PDB entry: 2DTO). The 
Lys111 was proposed to play a key role in the formation of biotinyl-5’-AMP in PhBPL by stabilising the 
pentacoordinate transition state of the α-phosphate before formation of the phosphoanhydride bond.18 In the 
AaBPL:biotin:ATP complex the equivalent conserved lysine (Lys103) adopts a similar conformation but 
forms long-range hydrogen-bonds with the carboxyl group of the biotin. 
Of particular note are the specific orientation and the interactions made by the Arg40 residue in the structure 
of the AaBPL complex which differ significantly from those in the PhBPL and BirA substrate 
complexes.
14,16,18
. Arg40 plays an essential role in stabilising the biotin and ATP ligands within the active site 
(Figures 2b and 3). In the AaBPL:biotin:ATP ternary complex, the side chain of Arg40 interacts with the 
carboxyl group of the biotin and forms direct hydrogen-bonds with the oxygens of the α- and β- phosphates of 
ATP. The backbone NH of the Arg40 residue also interacts with the carboxyl group of the biotin. This 
orientation of the conserved arginine side chain has not been observed in other ligand-bound BPL structures. 
In the structure of the BirA:biotin complex, the backbone NH of the equivalent arginine (Arg118) forms 
hydrogen-bonds with the carboxyl group of the biotin and in the complex with biotinol-5’-AMP, the backbone 
NH interacts with the oxygen atoms of the phosphate group of the adenylate.
14,16 
Thus, in the BirA complexes, 
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the side chain of the Arg118 appears to play mainly a structural role by closing the active site and sequestering 
the ligands via weak hydrophilic interactions. In the PhBPL:biotin:ATP complex the Arg48 strongly stabilises 
the α-phosphate of ATP by hydrogen-bonding via its backbone NH and weakly through its sidechain.. While 
in the structure of the AaBPL:biotin:ATP complex the side chain of the Arg40 adopts a bent conformation in 
order to interact with the biotin and the α- phosphate, in the PhBPL:biotin:ATP complex, the side chain of the 
Arg48 points towards the γ-phosphate and has a similar orientation with respect to the triphosphate chain 
(Figure 3). This conformation of the Arg48 allows the side chain to form a network of weak hydrogen-bonds 
with the oxygen atoms of the α- and β-phosphate groups of ATP (as well as with the phosphate of the biotin in 
the PhBPL:biotinyl-5’-AMP complex). In contrast to AaBPL, neither the backbone NH nor the side chain of 
the Arg48 interacts with the carboxyl group of the biotin in PhBPL. These combined analyses suggest that 
their are subtle differences in the way each BPL isozyme achieves substrate binding and 
catalysis. 
 
 
Figure 3.  Comparison of the ligand-binding sites of the ATP and biotin-bound complexes of AaBPL 
and PhBPL. The PhBPL PDB file used was 2DTO. The colouring is as follows: AaBPL, red cartoon; ATP, 
biotin and Arg40 shown as sticks with purple carbons; PhBPL, blue cartoon; ATP, biotin and Arg48 are 
shown as sticks with light blue carbons. The equivalent arginine residues and ATP are shown to be in 
significantly different positions. 
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4. The Crystal structure of the AaBPL R40G:biotin complex 
Cronan and colleagues had previously noted that an E. coli BirA R118G mutant, previously generated by 
early mutational studies and analysed Kwon and Beckett, was a “promiscuous” biotinylating enzyme.22,25,29,30 
This BirA R118G is defective in binding of both biotin and biotinyl-5’-AMP whereas ATP is bound normally. 
The dissociation constant of the R118G mutant for biotinyl-5’-AMP binding is 400-fold greater than that of 
wild type BirA whereas the biotin binding constant is 100-fold reduced. In the E. coli enzyme this loop is 
important for biotin and adenylate intermediate binding only. To explore the effect of the mutation observed 
with BirA R118G, the conserved Arg40 residue in AaBPL was similarly mutated to glycine generating an 
AaBPL R40G mutant. This enzyme crystallised under similar conditions to the native ligase but the mutation 
had an impact on the growth of the crystals and significantly reduced the rapid nucleation observed with 
native AaBPL. The crystal structure of the mutant AaBPL R40G was determined in complex with biotin and 
the density for the R40G containing loop and for bound biotin is clear, indicating that biotin binding stabilises 
the loop (Figure 4a). The main conformational differences observed between the structures of the mutant and 
the wild-type enzymes are within the active site. The biotin binding mode of the AaBPL R40G:biotin complex 
closely resembles that of the ATP-biotin complex of the wild type enzyme. While the ureido group and 
thiophene ring show near identical interactions with the wall formed by the 6- and 7- strands in both 
structures, in the mutant the carboxylate group of biotin is shifted towards the side chains of Lys103 and 
Asp96 on the β6- and β7- strands. 
The biotin:ATP binding loop (residues 37-47) containing the R40G mutation adopts a dramatically different 
conformation to the one observed in the AaBPL:biotin:ATP wildtype complex structure (Figure 4b). As a 
result, the interactions with the glycine-rich motif 37GRGGLG42 have changed significantly and the ATP 
binding site is now blocked by the mutated loop. The carboxylate group of the biotin interacts via hydrogen-
bonds with the backbone NH of the mutated Gly40, which occupies a position intermediate between the 
previously described ATP and biotin positions. The R40G mutation has caused the side chain of Arg38 to 
adopt a different orientation and point towards the oxygen atom of the biotin ureido group. The backbone and 
side chain of Leu41 have shifted towards the active site and now blocks ribose sugar binding. The strong 
hydrogenbond formed between the backbone NH of the Gly42 and the backbone carbonyl of the Gly40 
stabilises the turn of the loop formed by the aliphatic, mutated GRGGLG glycinerich motif. While in the wild-
type complex structure the side chain of the Arg43 interacts with the α-phosphate of ATP, in the structure of 
the mutant complex the side chain of this residue points towards the solvent. The mutated loops undergoes a 
single helical turn between residues Lys44 and Gln48 with the resultant repositioning of the Trp45 sidechain 
preventing binding of the adenine ring of ATP. Furthermore, the side chain of Leu46, which contributes to the 
stabilisation of ATP in the native AaBPL:biotin:ATP complex, is repositioned to weakly interact with the 
aliphatic chain of the biotin in the structure of the mutant complex. 
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(a)  
(b)  
 
Figure 4. A close-up stereo view of the mutant R40G AaBPL:biotin complex binding site. (a) Electron 
density is shown around the R40G containing loop (blue chickenwire) and the biotin ligand (green 
chickenwire). The final omit |Fo| – |Fc| map contoured at 3σ is shown. (b) Comparison of the loop position 
between AaBPL R40G:biotin complex and wild type AaBPL:biotin:ATP complex. The mutant loop and 
bound biotin are coloured green. ATP, biotin and Arg40 are shown as sticks in the native structure with grey 
coloured carbons. The mutant loop position can be clearly seen to preclude ATP binding. 
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5. Binding studies 
Isothermal titration calorimetry (ITC) experiments were carried out to determine the thermodynamic 
parameters for binding of biotin and ATP with AaBPL, and to investigate if the binding events occur via the 
ordered sequential mechanism established for BirA previously. Since the final step of the mechanism, the 
formation of biotinyl-5’- AMP, is Mg2+ dependent, the binding of the ligands was studied in the presence of 4 
mM EDTA.
31
 This is a valid simplification since the crystal structure of AaBPL complexed with biotin and 
ATP indicates that Mg
2+
 ions are not required for binding of the substrates. The ITC results indicate that 
AaBPL binds both substrates in an exothermic process (Figure 5a and 5b). The thermodynamic parameters 
(Table 1) suggest relatively weak protein-ligand interactions for both biotin and ATP binding under these 
conditions (KD = 3.5 μM and KD = 7.2 μM respectively), the interaction with biotin being 1000-fold weaker 
than that reported for biotin with BirA (KD = 45 nM).
22
 ATP and biotin binding are enthalpy-driven with a 
favourable entropy change. For an ordered mechanism to occur, binding of one ligand would be prerequisite 
for binding of the other. However, in contrast to BirA, biotin is not required for ATP binding to AaBPL. This 
result is unlikely to be an artefact since it could be shown by streptavidin titration that less than 4% biotin was 
present in the AaBPL preparation and thus the amount of biotin initially present in the active site could be 
ignored (see supplemental data). The small difference (a factor of 2) between the KD values for binding of 
ATP and biotin suggests that ligand binding to AaBPL occurs via a random process. 
 
Table 1. Thermodynamic parameters derived from the titrations of AaBPL and AaBPL R40G with 
biotin and ATP before and after formation of the binary complexes formed with the two ligands. 
 
The error in ΔH is ± 5% and is mainly due to the differences in enzyme and ligand concentrations. ΔGo is 
calculated from the binding determined by ITC: ΔG° = -RT lnKA = ΔH – T. ΔS
o
. KA = 1/KD. The parameters 
of BirA and BirA R118G binding to biotin are included in the table for comparison.
22, 23
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Figure 5. Isothermal titration calorimetry measurements of AaBPL with (a) biotin and (b) ATP and AaBPL 
R40G with (c) biotin and (d) ATP. The upper panels show the raw data of heat changes upon addition of 
ligand. The lower panels show the processed data corresponding to the heat of each injection plotted against 
the molar ratio of ligand to enzyme after subtraction of the heat of ligand dilution. All buffers contained 
10 mM Hepes pH 7.5, 4 mM EDTA. The derived thermodynamic parameters are given in Table 1. 
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The cooperativity of the binding events after formation of the binary complexes AaBPL:biotin and 
AaBPL:ATP was further investigated by titration with ATP and biotin, respectively. The ITC results revealed 
that binding of biotin and ATP was greatly enhanced by the presence of the other substrate. The affinity (KA) 
of biotin with the AaBPL:ATP binary complex is five times greater than for AaBPL alone (KD = 0.7 μM 
compared with 3.5 μM), while the KA of ATP for AaBPL increases nearly two-fold for the AaBPL:biotin 
complex (4.6 μM compared with 7.2 μM, Table 1). The enthalpy and entropy changes measured for the two 
possible pathways—i and iii, and ii and iv—leading to the formation of the AaBPL:biotin:ATP ternary complex 
correspond within experimental error and indicate cooperativity between biotin and ATP binding (Figure 6). 
Despite relatively large variations in apparent enthalpy and entropy changes for the different AaBPL binary 
and ternary complexes, the overall changes in binding free energies are much smaller and this may be 
attributed to the ubiquitous enthalpy–entropy compensation frequently observed in biomolecular systems.33 
 
 
 
Figure 6.  Formation of the ternary AaBPL:biotin:ATP complex via the pathways i and iii, and pathways ii 
and iv. In AaBPL, both pathways occur. KA is the association constant (1/KD). 
 
To investigate the role of Arg40 in the ligand binding process, ITC experiments were also performed with 
theAaBPL R40G enzyme. Titrations of this mutant under the experimental conditions used for the wild type 
indicated that the affinity for biotin is only 2.5-fold lower than that observed for the native enzyme (KD 8.3 μ
M compared with 3.5 μM; see Figure 5c and Table 1). This suggests that, in contrast to the E. coli mutant 
BirA R118G, which displayed greatly reduced biotin binding, the Arg to Gly mutation has little effect on 
biotin binding in AaBPL. Thus, while the affinity of BirA for biotin is approximately 100-fold greater than 
that ofAaBPL, the dissociation constants for the biotin complexes of the two mutants BirA R118G and AaBPL 
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R40G are similar (KD 1.8 μM and 8.3 μM, respectively).
22
 Both apparent enthalpy and entropy changes are 
favourable for biotin binding to the mutant (Table 1). Biotin was shown to bind to AaBPL R40G withKD = 
15.4 μM when the mutant was titrated in the presence of ATP. The small difference, a factor of <2, between 
the measured dissociation constants for the AaBPL R40G and the AaBPL R40G binary complex suggests that 
the presence of ATP does not significantly alter biotin binding. 
In contrast to the biotin data, titrations of the mutant enzyme with ATP showed only small heat signals, 
principally due to heat of dilution, indicating that binding of ATP to the AaBPL R40G is negligible (KD > 200 
μM) under these conditions (Figure 5d). The side chain of Arg40 thus appears to be necessary for ATP 
binding in the absence of Mg
2+
. The structure of the mutant AaBPL R40G:biotin complex revealed that biotin 
binding affects the conformation of the ATP-binding pocket and titration of this complex with ATP also 
showed very weak binding (KD > 200 μM). 
 
6. Substrate biotinylation with AaBPL R40G 
Previously, we showed that the C-terminal domain of A. aeolicus BCCP (BCCPΔ67) is a substrate for 
biotinylation with AaBPL.
21
 Incubation of apo-BCCPΔ67 with AaBPL or the mutant AaBPL R40G in the 
presence of biotin, ATP and MgCl2 for 20 min at 65 °C led to the formation of biotinylated-BCCPΔ67. 
While, on the basis of streptavidin Western blots of the reactions, the R40G mutant appears to be a poorer 
catalyst than the wild type enzyme (Figure 7a, lanes 9 and 10), mass spectrometry of the biotinylated BCCPΔ
67 from the R40G-catalysed reaction revealed the formation of a singly biotinylated BCCPΔ67 species with a 
mass increase equivalent to one biotin moiety (10,740.7 – 10,966.2 Da) (Figure 8c). The mutant substrate 
BCCPΔ67 K117L, which lacks the target Lys117, is not biotinylated by AaBPL or by AaBPL R40G, 
showing that none of the remaining four lysine residues was derivatised and suggests a significant degree of 
target specificity (Figure 7a, lanes 12–14). However, Western blots of these reactions also showed that AaBPL 
R40G, in contrast to the wild type enzyme, self-biotinylates (Figure 7a). This was confirmed by mass 
spectrometry analysis of the R40G species after incubation; mass increases in the range 200 ∼ 2000 Da (data 
not shown) were observed, indicating that the single R40G mutant, which contains lysine residues, undergoes 
multiple biotinylation. 
The equivalent BirA mutant, BirA R118G, has been shown to biotinylate itself in vivo and in vitro, and to 
biotinylate non-cognate acceptors such as bovine serum albumin (BSA) or RNAse A.
25
 On the basis of the 
fact that BirA R118G binds biotinyl-5′-AMP less tightly than wild-type BirA (KD 20 nM and KD 45 pM, 
respectively), it has been suggested that this could be a direct consequence of non-specific solution reactions 
of free biotinyl-5′-AMP with exposed lysine residues. 22,25 Our suggestion that A. aeolicusBCCPΔ67 
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K117L is not multiply biotinylated is supported by recent chemical biotinylation studies of E. coliBCCP87 
with free biotinyl-5′-AMP, which have demonstrated that only the target lysine is modified.33 This 
specificity has been attributed to the intrinsic reactivity of the target lysine and the stabilisation of the 
BCCP:biotinyl-5′-AMP complex through interactions of the ureido ring of the biotin moiety with residues 
of the “thumb” region present in both E. coli and A. aeolicus BCCP. 21,34 
 
 
Figure 7.  Streptavidin Western blot analysis of biotinylation with wild type AaBPL and mutant AaBPL 
R40G, and with BSA of (a) apo-BCCPΔ67 and BCCPΔ67 K117L and (b) BSA. (a) Left-hand panel: SDS-
PAGE stained with Coomassie brilliant blue (lanes 1–7); right-hand panel: Western blot (lanes 8–14). Lanes 1 
and 8, apo-BCCPΔ67; lanes 2 and 9, apo-BCCPΔ67 incubated with AaBPL in the presence of biotin, ATP, 
MgCl2 at 65 °C for 20 min; lanes 3 and 10, apo-BCCPΔ67 incubated with AaBPL R40G under the same 
conditions as wild type AaBPL; lanes 4 and 11, BCCPΔ67 K117L; lanes 5 and 12, BCCPΔ67 K117L 
incubated with AaBPL in the presence of biotin, ATP, MgCl2 at 65 °C; lanes 6 and 13, BCCPΔ67 K117L 
incubated withAaBPL R40G under the same conditions; lanes 7 and 14, BCCPΔ67 K117L incubated with 
AaBPL R40G in the presence of 100 μM biotin, ATP, MgCl2 at 65 °C. The intensity of the AaBPL R40G 
spot (in lane 10), given that the protein concentrations of R40G and BCCPΔ67 are 1/10 indicates the multiple 
nature of R40G self-biotinylation. This was confirmed by mass spectrometry. (b) BSA (2 μM) incubated in 
the presence of biotin, ATP, MgCl2 at 65 °C for 20 min with AaBPL or AaBPL R40G. Lane 1, BSA; lane 2, 
BSA with 50 nM AaBPL; lane 3, BSA with 50 nM AaBPL R40G; lane 4, BSA with 200 nM AaBPL; lane 5, 
BSA with 200 nM AaBPL R40G; lane 6, BSA with 500 nM AaBPL; lane 7, BSA with 500 nM AaBPL R40G. 
Page 17 of 31 
To determine whether AaBPL and AaBPL R40G could also carry out non-specific biotinylation, the enzymes 
were incubated with biotin, ATP and MgCl2 in the presence of (BSA) at 65 °C. Western blot analysis of the 
products revealed that, while biotinylation of BSA did not occur in the presence of substrates alone or at low 
concentration of wild-type AaBPL, the mutant AaBPL R40G biotinylated itself and BSA in a manner similar 
to that shown for BirA R118G (Figure 7b). At high concentrations of enzyme, the wild-type AaBPL also 
carried out self-biotinylation and non-specific biotinylation of BSA, albeit less effectively. 
AaBPL R40G appears to self-biotinylate preferentially rather than derivatise the substrates BSA or BCCPΔ67 
(Figure 8a and b), which is likely to be a consequence of the elevated temperature of the reaction with the 
thermostable enzymes. Since chemical biotinylation with biotinyl-5′-AMP is proximity-dependent and the 
lifetime of AMP mixed anhydrides in aqueous solution (typically t1/2 ∼ 1 min at pH 7, 25 °C) will be 
significantly shorter at 65 °C, the amount of reagent surviving to modify a non-cognate acceptor will be 
significantly less. 
25,35
 
 
Figure 8. LC-ESI-MS analysis of apo-BCCPΔ67: the 6+ to 10+ charge states and the deconvoluted masses. 
(a) apo-BCCPΔ67 incubated in presence of biotin, ATP, MgCl2 at 65 °C for 15 min; (b) apo-BCCPΔ67 
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incubated with AaBPL in the same conditions; (c) apo-BCCPΔ67 incubated with AaBPL R40G in the same 
conditions. The theoretical mass for apo-BCCPΔ67 is 10,739.63 Da and the theoretical mass for holo-BCCP
Δ67 is 10,965.94 Da. 
 
Conclusion 
We have determined the crystal structures of the monomeric class I AaBPL in the ligand-free form and in 
complex with biotin and ATP. We found that AaBPL displays a high level of structural similarity with the E. 
coli BirA and P. horikoshii BPL enzymes with regard to the domain arrangement and overall fold. 
16, 18
The 
geometry of the novel AaBPL:biotin:ATP complex presented here suggests that it is similar to that of the 
transition state that precedes biotinyl-5′-AMP formation. In the structure of the AaBPL:biotin:ATP complex, 
the biotin co-factor and the AMP moiety of ATP are buried in the adenylate-binding site, and the biotin 
carboxylate and the α-phosphate are located in close proximity to each other at the entrance of the active site. 
This suggests that subsequent nucleophilic attack of the carboxylate anion on the α-phosphate leading to the 
formation of the phosphoanhydride bond of the product requires only minor changes to the conformation of 
the active site and may be facilitated by Mg
2+
 binding to the β- and γ-phosphates of ATP, which are 
solvent-exposed and located in the inter-subunit domain formed by the N- and C-termini. The oxygen atoms 
of the ATP γ-phosphate form long-range hydrogen bonds with residues located on the SH3-like barrel C-
terminal domain also characterized in the structural homologue phenylalanine tRNA synthetase.
8
 This is the 
first demonstration that direct interactions of the substrates and the C-terminal domain of a BPL occur. This 
has been further highlighted in the recent co-crystal structures of PhBPL R48A and K111A with BCCPΔ
N76, the C-terminal domain shows the largest variations in the different stages of the complex, which 
suggests its functional importance in this isoform.
19
 
The bent conformation of the adenylate described in the PhBPL:biotinyl-5′-AMP and BirA:biotinol-5′-
AMP complexes has also been observed in the structural homologue Thermoplasma acidophilum LplA 
(TaLplA) bound to lipoyl-AMP. 
36,37
 However, the orientation of the triphosphate chain of ATP is not 
conserved in these enzymes. In the structure of TaLplA bound to MgATP, the ATP moiety adopts a U-shaped 
conformation and the phosphate chain points inward towards the bifurcated lipoyl-AMP-binding pocket, 
which is accessible through a tunnel-like entrance. The β-phosphate occupies roughly the same position as 
the carboxyl group of lipoyl-AMP inside the predominantly hydrophobic cavity. The U-shaped conformation 
of ATP is also observed in the structures of class II aminoacyl-tRNA synthetases bound to ATP but here the 
β- and γ-phosphates remain solvent-exposed. For example, comparison of the structures of Thermus 
thermophilus glycyl-tRNA synthetase bound to ATP and glycyl-AMP show that the ATP phosphate chain, 
located at the entrance of the active site, is bent away from the binding site of the glycyl moiety. The resultant 
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aminoacyl-adenylate adopts an extended conformation.
38
 Analysis of the structures ofStaphylococcus aureus 
threonyl-tRNA synthetase bound to ATP and Zn
2+
 and to an adenylate analogue (threonyl-AMS) and the 
structures of the MgATP and alanine complexes of A. aeolicus alanyl-tRNA synthetase supports this common 
binding mode in class II tRNA synthetases.
39,40
  
The structure of the AaBPL:biotin:ATP complex has revealed the importance of Arg40 from the glycine-rich 
motif in the stabilisation of the two ligands. The side chain of this conserved arginine plays an important role 
in the neutralisation of the negative charges of the triphosphate chain of ATP as well as positioning the biotin 
carboxylate in close proximity to the α-phosphate. The side chain interacts with the ATP phosphate chains in 
two different ways in the A. aeolicus and P. horoikoshii BPL:biotin:ATP ternary complexes. In the AaBPL 
complex, Arg40 satisfies only the negative charges of the α- and β-phosphates, and leads to a requirement 
for a metal ion for catalysis. Mutation of the arginine to glycine resulted in the dramatic collapse of the 
substrate-binding loop. The crystal structure of AaBPL R40G bound to biotin shows that the mutated binding 
loop is ordered but blocks the ATP-binding pocket. In contrast, in the structures of the mutant PhBPL R48A 
complexes, the Ala48 side-chain adopts the same orientation as that of the Arg48 of the wild-type PhBPL 
complexes and the turn of the loop containing the 45GHGRLN50 motif shows very little conformational change 
in any native or mutant structures of PhBPL.
19
 
To investigate the effects of the R40G mutation on substrate binding in solution, comparative ITC 
experiments were carried out with wild-type AaBPL and mutant AaBPL R40G. The ITC analysis showed 
thatAaBPL binds biotin and ATP randomly, and that the binding events occur via a cooperative process. This 
contrasts with the behaviour of E. coli BirA, where binding of the substrates follows a sequential ordered 
mechanism in which formation of the BirA:biotin complex is a prerequisite for ATP binding.
16
 The ordering 
of binding exhibited by BirA appears necessary in view of its dual role as a repressor and ligase 
41,42
 —it makes 
sense that recruitment of ATP should be the second step. In contrast, for a monofunctional BPL such as 
AaBPL, which lacks a regulatory role, the binding order is not crucial. The BirA adenylate-binding loop, 
which has been shown to be involved in ATP binding and dimer packing, is disordered in the structures of the 
ligand-free and the biotin-bound BirA complexes. 
14,15
 In contrast, this loop is organised in the ligand-free 
form of AaBPL, resulting in a well defined ATP-binding pocket. The Km values of AaBPL and BirA for ATP 
also reflect the greater affinity of AaBPL for the nucleotide (15 μM and 200 μM, respectively) while the 
Kmvalues for biotin are similar (440 nM and 300 nM, respectively). 
24,28
 The order of binding of the substrate 
and ATP in the adenylate-synthesising enzymes appears to be peculiarly isozyme-specific, since the 
eukaryotic class IV BPL from Saccharomyces cerevisae binds ATP before biotin, while amino acid and ATP 
binding is a random process in the class II tRNA synthetases. 
43,44
 
The collapse of the substrate-binding loop observed in the structure of the R40G mutant adversely affects 
ATP binding but does not inactivate the enzyme completely (vide infra). We used mass spectrometry and 
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streptavidin Western blot studies to reveal that AaBPL R40G can catalyse the formation of biotinyl-5′-AMP 
in the presence of high concentrations of ATP and promiscuously biotinylate the target lysine of apo-BCCPΔ
67, and residues on BSA and the mutant itself. It can be envisaged that, as a consequence of the changed 
conformation of the binding site, the AaBPL R40G:biotinyl-5′-AMP binary complex can dissociate and 
release the adenylate in the absence of the acceptor protein. Similar behaviour has been observed with the 
BirA mutant R118G and in native E. coli methionyl-tRNA and valyl-tRNA synthetases. 
25,45,46
 In the structure 
of PhBPL R48A K111A co-crystallised with biotin and ATP, the disordered triphosphate chain reduces the 
reactivity between the ligands and the authors subsequently used this double mutant (and the PhBPL R48A 
single mutant) to allow co-crystallisation with PhBCCPΔN76, the structure of which was reported during the 
final stages of preparation of our manuscript.
19
 It is interesting to note that in the PhBPL R48A 
K111A:PhBCCPΔN76 complex, the biotinyl domain is in the holo form and also contains bound biotin and 
adenosine, suggesting that the double mutant is catalytically active. Multiple conformations of the proteins 
were observed in the crystals obtained by Bagautdinov and colleagues, giving them a view of the enzyme 
throughout the catalytic process. They propose a catalytic dyad role for residues Asn103 and Asp104 
(conserved as Asn95 and Asp96 in AaBPL), that orientates and deprotonates the target lysine. On the other 
hand, the PhBPL BCCP does not contain the conserved thumb found in E. coli and A. aeolicusBCCPs, and it 
appears that the biotinylation process in different species has subtle nuances that require detailed individual 
study. 
Our study sheds light on the effects of mutation within the biotin-binding loop on substrate specificity of the 
bacterial BPLs and may provide insight into the molecular basis of human multiple carboxylase deficiency 
syndrome (MCD). This disease is linked to mutations in the human holocarboxylase synthetase enzyme 
(HCS), a class IV BPL. It has been demonstrated that the minimum functional HCS protein is retained in the 
349 C-terminal amino acids, which show highly conserved sequence similarity to the putative biotin-binding 
domain of bacterial BPLs.
47
 Further deletion of the N-terminus of the human enzyme to allow comparison 
with the 276 amino acids of AaBPL resulted in 33.3 % sequence similarity and 19.2 % sequence identity 
between the human HCS domain and the A. aeolicus enzyme. A commonly recurring HCS mutation leading 
to MCD in the 505GKGRGG510 motif is R508W which maps to Arg40 of AaBPL. Patients with this missense 
R508W mutation are responsive to biotin and can be treated clinically with pharmaceutical doses of the 
vitamin. 
48,49
 It seems likely that further studies on the bacterial proteins may uncover details of enzyme action 
relevant to this area of human biochemistry.
50
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Materials and Methods 
Materials 
All chemicals used in the preparation of buffers were at least reagent grade. D-Biotin was purchased from 
Sigma. For analysis with Western blot, the blocking solution (SuperBlock® Blocking buffer in PBS) was 
obtained from Pierce and the antibody (Streptavidin HRP) from BD Pharmingen™. The BSA used for the in 
vitro biotinylation experiment with AaBPL R40G was also obtained from Pierce. For the DNA manipulations, 
PCR was done using Ready To Go PCR™ beads (Amersham) and the QIAprep® Spin Miniprep kit was 
obtained from Qiagen. Restriction endonucleases were purchased from New England Biolabs. 
 
Expression and purification of AaBPL 
AaBPL was expressed and purified essentially as described but with the following modifications.
21
 The cell 
pellet, suspended in 10 mM Hepes pH 7.5 containing one tablet of Complete™ Proteinase Inhibitor Cocktail 
(Roche), was lysed by sonication (15 min of 30 s cycle). The cell lysate was clarified twice by centrifugation 
in the presence of DNase (Roche). The protein was then purified on a Tricorn H R 10/100 column loaded with 
15S beads (Amersham) and eluted with a linear salt gradient (0–1 M NaCl in 10 mM Hepes pH 7.5). 
 
Cloning, expression and purification of mutant AaBPL R40G 
Site-directed mutagenesis was carried out with the Stratagene kit. The complementary oligonucleotides 
encoding the desired mutation were obtained from Sigma Genosys (AaBPL R40G for: GGA AGG GGA GGA 
CTC GGA AGG AAG TGG CTC, AaBPL R40G rev: GAG CCA CTT CCT TCC GAG TCC TCC CCT 
TCC).The mutant AaBPL R40G was then expressed and purified as described for wild-type AaBPL. 
 
Crystallisation of apo-AaBPL, AaBPL:biotin:ATP and mutant AaBPL R40G and AaBPL R40G:biotin 
The purified protein AaBPL was concentrated to 5 mg/ml and crystallised by the hanging drop, vapour 
diffusion method at 17 °C. Each crystallisation drop contained 2 μl of protein solution and 1 μl of the 
reservoir solution (0.1 M Mes, 0.2 M ammonium sulphate, 15 % (w/v) PEG 5000 mono-ethyl ether, pH 6.5). 
To limit nucleation due to impurities, the protein was centrifuged for 1 h at 13,000 rpm before crystallisation. 
The crystals appeared immediately and grew non-reproducibly in a few hours to approximately 0.5 mm in 
length. In the case of the AaBPL:biotin:ATP complex, D-biotin (2 mM, 1 M NaOH final concentration) and 
ATP (5 mM, pH 7 final concentration) were added to the protein before centrifugation and crystallisation. 
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AaBPL R40G was crystallised by the hanging drop, vapour diffusion method at 17 °C at a concentration of 6 
mg/ml. 
Crystal trials of the apo form of the AaBPL R40G mutant protein were done by the hanging drop, vapour 
diffusion method at 17 °C. The rapid and extensive nucleation observed with wild-type AaBPL was 
significantly reduced and it took 4–14 days for the crystals to grow. Co-crystallization of the AaBPL R40G 
mutant (carried out at 4 °C and 17 °C) in the presence of 2 mM biotin and 5 mM ATP afforded a 
heterogeneous mixture of low-quality crystals of various shapes and lengths, while crystals of AaBPL R40G 
co-crystallised with ATP (5 mM), indicating no electron density for the ligand. We obtained crystals of the 
mutant in the presence of biotin alone; each drop contained 2 μl of protein (6 mg/ml) in the presence of 2 
mM D-biotin and 1 μl of the reservoir solution (0.1 M Mes, 0.2 M ammonium sulphate, 10 % (w/v) PEG 
5000 mono-ethyl ether, pH 6.0) at 17 °C. The rectangular crystals took one week to grow reproducibly and 
were ∼0.5 mm in length. 
For data collection, the AaBPL and AaBPL R40G crystals were frozen after being transferred into a 
cryoprotectant solution containing the reservoir solution supplemented with either 20 % (v/v) glycerol or a 
non-drying immersion oil (Cargille Laboratories Inc). 
 
Data collection and structure analysis 
Data were collected at station BM14 ESRF Grenoble and station 10.1 SRS Daresbury. Data were processed 
using the programs MOSFLM and SCALA as part of the CCP4 suite of programs and the structure was solved 
with the program PHASER
 
using the structure from P. horikoshii (PDB code 1WPY). Initial refinement was 
done using the program REFMAC and finished using the program phenix.refine as part of the PHENIX 
package.
53,54
 Manual refinement was performed using the program COOT.
55
 Details of the X-ray data 
collection, processing and statistics are presented in Table 2. 
 
Table 2. X-ray data collection, processing and refinement statistics. → 
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Isothermal titration calorimetry 
Isothermal titration calorimetry measurements were performed on a VP-ITC calorimeter (Microcal Inc). All 
experiments were carried out at 25 °C in 10 mM Hepes, 4 mM EDTA, pH 7.5. The reactants (15.4 μM 
wild-type AaBPL and 18 μM mutant AaBPL R40G) were placed in the 2 ml sample chamber and the 
substrates D-biotin and ATP (0.2 mM) in the syringe were added with 29 successive additions of 10 μl for 20 
s (with an initial injection of 1 μl). The interval between each injection lasted 180 s. The peaks generated 
were corrected for ligand heat of dilution and integrated using the ORIGIN software (Microcal Inc) by 
plotting the values in microcalories against the molar ratio of injectant to reactant within the cell. Data were 
fitted using the single-site binding model. From the dissociation constant KD and the reaction enthalpy value 
ΔH, the change in free Gibbs energy (ΔGo) and entropy change (ΔSo) can be calculated using the equation 
ΔGo=RTln(1/KD)=ΔH−TΔSo where R is the universal gas constant and T is the absolute temperature. 
 
In vitro biotinylation studies of BSA, apo-BCCPΔ67 and BCCPΔ67 K117L by mutant AaBPL R40G 
All in vitro biotinylation experiments, unless stated otherwise, were done in 10 mM Hepes, pH 7.5 at 65 °C 
for 15 or 20 min and were terminated by addition of SDS sample buffer or 0.1 % (v/v) TFA. In the 
biotinylation studies with BSA, 2 μM BSA was incubated with 5 μM d-biotin, 1 mM ATP, 2 mM MgCl2 
and 50, 200, or 500 nM wild-type AaBPL and mutant AaBPL R40G. Biotinylation experiments were also 
carried out with the apo form of BCCPΔ67 and with the mutant BCCPΔ67 K117L. The substrates apo-
BCCPΔ67 and BCCPΔ67 K117L were expressed and purified as described previously.21 For the streptavidin 
Western blot studies, the reaction mixtures contained 2 μM substrate, 5 μM D-biotin, 1 mM ATP, 2 mM 
MgCl2 and 200 nM enzyme AaBPL orAaBPL R40G. For the mass spectrometry analysis, 10 μM apo-BCCP
Δ67 was incubated with 100 μM D-biotin, 1 mM ATP, 2 mM MgCl2 and the reaction was initiated by 
addition of purified AaBPL R40G to a final concentration of 2 μM. 
 
Streptavidin Western blot analysis 
Pure proteins separated by SDS-PAGE were transferred onto a 0.2 μm pore sized Hybond-ECL 
nitrocellulose membrane (Amersham) using a Trans blot Semi-Dry Transfer cell. The membrane was 
incubated overnight in the biotin-free SuperBlock solution at 4 °C. Excess blocking solution was then 
removed by washing with phosphate buffer containing 0.1% (v/v) Tween (Sigma) four times before 
incubation in SuperBlock solution containing 1/50,000 Streptavidin HRP for 1 h at room temperature. The 
membrane was washed and dried before immunolabelled proteins were detected using the ECL enhanced 
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chemiluminescence detection system (Amersham) in accordance with the manufacturer's protocol. Proteins 
were visualised on BioMax XAR film (Kodak). 
 
Mass spectrometry 
Positive electrospray ionisation (ESI) liquid chromatography (LC-ESI-MS) was used for the characterisation 
of AaBPL, AaBPL R40G and biotinylated BCCPΔ67. Protein samples were separated using a Phenomenex 
C5 reverse phase column on a Waters HPLC 2690. The proteins were eluted from the column with a 5%–95% 
(v/v) acetonitrile gradient (containing 0.1 % TFA) and analysed on a MicroMass Platform II quadrupole mass 
spectrometer. The molecular mass was determined by the Transform algorithms of the Mass Lynx software 
(MicroMass). 
 
Protein Data Bank accession codes 
The coordinates have been submitted to the PDB. The apo form of AaBPL has been assigned the PDB 
code3FJP, the AaBPL:biotin:ATP complex has PDB code 3EFS and the AaBPL R40G:biotin complex has 
PDB code 3EFR. 
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